Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)
23/10/2024 14:01
Oct 23 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA ENTERS INTO DEFINITIVE MERGER AGREEMENT WITH
DOUBLE
POINT VENTURES TO GO PRIVATE VIA A TENDER OFFER OF $4.25 CASH
PER SHARE PLUS CONTINGENT VALUE RIGHTS (CVR)
* LUMOS PHARMA ENTERS INTO DEFINITIVE MERGER AGREEMENT WITH
DOUBLE
POINT VENTURES TO GO PRIVATE VIA A TENDER OFFER OF $4.25 CASH
PER SHARE PLUS CONTINGENT VALUE RIGHTS (CVR)
* LUMOS PHARMA INC: PROPOSED DEAL FOR TOTAL EQUITY VALUE OF
APPROXIMATELY $38 MILLION
* LUMOS PHARMA INC: LUMOS PHARMA WILL CONTINUE AS AN
INDIRECT
WHOLLY-OWNED SUBSIDIARY OF DPV
* LUMOS PHARMA INC: WITHDRAWS ITS PRIOR CASH RUNWAY GUIDANCE
Source text for Eikon: ID:nGNX1zFpqm
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)